2-Bromo-3,6-difluoro-1-(difluoromethyl)benzene, 5g

4-(pyridin-3-yl)butan-2-one, 95.0%, 250mg

ethyl 5-chloro-2-fluorobenzoate, 1g

1H-BENZIMIDAZOLE, 6-BROMO-7-CHLORO-, 95.0%, 250mg

1-(5-Nitropyridin-2-yl)-3-piperidinecarboxylic acid, 1g

14-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12-TETRAOXATETRADECANOIC ACID, 95%, 100mg

GC capillary column ROTI®Cap-1701, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

2-Chloro-5-iodo-3-nitropyridine, 95.0%, 25g

tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 5g

2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazine-1-carbonyl)cyclohexane-1-carboxylic acid, 90%, 1g

BROMO-PEG2-BROMIDE, 95.0%, 250mg

7-Hydroxy-1-tetralone, 95.0%, 100g

2,3-Dichloro-1,4-naphthoquinone>95.0%(GC)25g